{"id":1397,"date":"2017-09-19T14:40:13","date_gmt":"2017-09-19T13:40:13","guid":{"rendered":"http:\/\/161.116.26.48\/que-fem\/tecnologies-materials-llicencies\/materials-disponibles\/"},"modified":"2026-06-09T12:24:17","modified_gmt":"2026-06-09T10:24:17","slug":"materiales-disponibles","status":"publish","type":"page","link":"https:\/\/www.fbg.ub.edu\/es\/que-hacemos\/tecnologias-materiales-y-licencias\/materiales-disponibles\/","title":{"rendered":"Materiales"},"content":{"rendered":"

[vc_row][vc_column]

Anti \u2013 Mouse CD69 hybridoma<\/span><\/div>
CD69.2.2<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-mouse
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: mouse
\nAPP RECOMMENDED: FACS, IF, IP
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti \u2013 Human SLAMF7 hybridoma<\/span><\/div>
SF7.3.14<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: human
\nAPP RECOMMENDED: FACS, IF, IP
\nRESEARCH GROUP OR IP: Dr. Pablo Engel\/Ana Angulo<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Mouse CD84 hybridoma<\/span><\/div>
mCD84.7<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Hamster anti-mouse
\nISOTYPE: IgG
\nSPECIES REACTIVITY: Mouse
\nAPP RECOMMENDED: FACS, IP
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Mouse CD84 hybridoma<\/span><\/div>
CD84.2.151<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: ELISA
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Mouse CD84 hybridoma<\/span><\/div>
CD84.1.21<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG2a
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: FACS
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Mouse CD229 hybridoma<\/span><\/div>
Ly9.7.144<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-mouse
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Mouse
\nAPP RECOMMENDED: FACS, IF, IP, in vivo agonistic efect
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Human CD229 (Ly9) hybridoma<\/span><\/div>
HLy9.1.25<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: IP, FACS
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Human CD244 (2B4) hybridoma<\/span><\/div>
2B4.69<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: IP, FACS
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Mouse CD244 hybridoma<\/span><\/div>
M2B4 (B6) 458. Recognizes B6 and related strains<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-mouse
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Mouse
\nAPP RECOMMENDED: IP, FACS
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Human CD150 (SLAMF1) hybridoma<\/span><\/div>
SLAM.4<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: FACS, Immunoprecipitation
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Rat CD38 hybridoma<\/span><\/div>
14.27<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-rat
\nISOTYPE: IgG2b
\nSPECIES REACTIVITY: Rat
\nAPP RECOMMENDED: FACS, immunoprecipitation
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - CD352 (SLAMF6) hybridoma<\/span><\/div>
hsF6.4.20<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE:
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: FACS, IP
\nRESEARCH GROUP OR IP: Dr. Pablo Engel\/Dra. Ana Angulo<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Human CD62P hybridoma<\/span><\/div>
p-sel.ko.2.12<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human, rat, goat, sheep
\nAPP RECOMMENDED: IP, FACS, Blocking
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>

Anti - Human CD62P hybridoma<\/span><\/div>
p-sel.ko.2.3<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human, rat, mouse
\nAPP RECOMMENDED: IP, FACS, Non-blocking
\nRESEARCH GROUP OR IP: Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]

Anti \u2013 Human CD38 Hybridoma<\/span><\/div>
CD38.2.196<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: FACS
\nRESEARCH GROUP OR IP: Dr. Pablo Engel\/Dra. Ana Angulo<\/p>\n<\/div><\/div><\/div><\/div><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]

Anti \u2013 Human CD199 Hybridoma<\/span><\/div>
CCR9.1.349<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG2a
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: FACS
\nRESEARCH GROUP OR IP: Dr. Pablo Engel\/Dra. Ana Angulo<\/p>\n<\/div><\/div><\/div><\/div><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]

Anti \u2013 TIGIT Hybridoma<\/span><\/div>
TIGIT.4.57<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human TIGIT
\nISOTYPE: IgG2a
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: Flow cytometry
\nRESEARCH GROUP OR IP: Dr. Ana Angulo\/Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>[\/vc_column][\/vc_row][vc_row][vc_column]

Anti \u2013 Human FcRL5a (CD307e) Hybridoma<\/span><\/div>
FcRL5a.1.10<\/span><\/div><\/div><\/div><\/div>\n
<\/div>

TYPE: Mouse anti-human
\nISOTYPE: IgG1
\nSPECIES REACTIVITY: Human
\nAPP RECOMMENDED: Flow cytometry
\nRESEARCH GROUP OR IP: Dr. Ana Angulo\/Dr. Pablo Engel<\/p>\n<\/div><\/div><\/div><\/div><\/div>[\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":1395,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-1397","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/pages\/1397","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=1397"}],"version-history":[{"count":20,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/pages\/1397\/revisions"}],"predecessor-version":[{"id":24508,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/pages\/1397\/revisions\/24508"}],"up":[{"embeddable":true,"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/pages\/1395"}],"wp:attachment":[{"href":"https:\/\/www.fbg.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=1397"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}